The Next Generation Biotech Media
In the virtual ASGCT21 meeting, a panel discussion focused on the preclinical and clinical updates of gene therapy interventions in cancer. Co-chairs Rayne Rouce, M.D., and Renata Stripecke, Ph.D., moderated …
Read More
Since its founding in 2000, Flagship Pioneering, one of Massachusetts’ largest venture capital firms, has launched numerous companies. A remarkable one among them is Moderna, which back in 2012 secured …
Read More
Over the last decade, several blockbuster immunotherapies have received FDA approval. During the virtual ASGCT meeting, experts reflected on the current trends and future directions of gene and cell therapies …
Read More
On May 11th, Ginkgo Bioworks and Soaring Eagle Acquisition Corp. agreed to a merger in what is one of the largest SPAC deals to date. Totaling $17.5 billion, the deal …
Read More
Ever since its discovery, CRISPR research has made advances in leaps and bounds to edit the genetic code. There have been many variations to the core technology that enable the …
Read More
Triple-negative breast cancer (TNBC) defined by lack of estrogen, progesterone, and the HER2 receptor accounts for 15% of all newly diagnosed breast cancers. With limited treatment options, the median overall …
Read More
In a recent publication in the Journal Nature Genetics, scientists from the Dana-Farber Cancer Institute discovered that CRISPR-Cas9 editing can initiate several errors in cell division that lead to whole-genome …
Read More
Exosomes, the lipid bilayer vesicles containing innumerable health and disease messengers, are smaller than 150 nm in diameter and released from cells after membrane fusion. They manage various physiological and …
Read More
KRAS is one of the most commonly mutated genes in cancers. It is present in approximately 90% of pancreatic cancers, 30%-40% of colon cancers, and 15%-20% of lung cancers. At the …
Read More
The virtual AACR conference featured a panel discussion on the development of Artificial Intelligence (AI) and Machine Learning (ML) in cancer research, where speakers addressed the challenges and progress in …
Read More